Sara E. Garwick-Coppens
Nationwide Children's Hospital(US)
Publications by Year
Research Areas
Muscle Physiology and Disorders, RNA Research and Splicing, Neurogenetic and Muscular Disorders Research, Cardiomyopathy and Myosin Studies, MicroRNA in disease regulation
Most-Cited Works
- → RNA Interference Inhibits DUX4-induced Muscle Toxicity In Vivo: Implications for a Targeted FSHD Therapy(2012)120 cited
- → AAV-mediated follistatin gene therapy improves functional outcomes in the TIC-DUX4 mouse model of FSHD(2018)74 cited
- → Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4(2016)53 cited
- → Human miRNA miR-675 inhibits DUX4 expression and may be exploited as a potential treatment for Facioscapulohumeral muscular dystrophy(2021)52 cited
- → RNA Interference Improves Myopathic Phenotypes in Mice Over-expressing FSHD Region Gene 1 (FRG1)(2011)45 cited
- → RNAi-mediated Gene Silencing of Mutant Myotilin Improves Myopathy in LGMD1A Mice(2014)17 cited
- → Rapid Cloning and Validation of MicroRNA Shuttle Vectors: A Practical Guide(2011)8 cited
- → Construction of permanently inducible miRNA-based expression vectors using site-specific recombinases(2011)6 cited
- → T.O.1 RNAi therapy for LGMD1A(2012)1 cited
- → Generation of a new, inducible model of FSHD that develops overt myopathic phenotypes(2017)